We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Highly Sensitive ELISA Technique for Bevacizumab Bioanalysis

News   Feb 01, 2018 | Original story from Bentham Science Publishers

 
Highly Sensitive ELISA Technique for Bevacizumab Bioanalysis

This is a schematic diagram of the ELISA for Bevacizumab. Credit: Bentham Science Publishers and Dr. Manal A. El-Gendy et al.

 
 
 

RELATED ARTICLES

Alzheimer's Trafficking Defect Corrected in Rodents

News

UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.

READ MORE

Immune System Kept in Check by Protein Police

News

Researchers learn how a key transcription factor helps regulate the immune system and could be critical to understanding autoimmune disease and cancer immunosuppression.

READ MORE

CRISPR Could Restore Effectiveness of Lung Cancer Treatment

News

The CRISPR-Cas9 gene editing system may be able to restore the effectiveness of first-line chemotherapies used to treat lung cancer by deleting or "knocking out" a gene in cancer tumors that helps the tumors develop resistance to the drugs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE